Unknown

Dataset Information

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.


ABSTRACT:

Importance

Little is known about how out-of-pocket burden differs between Medicare and commercial insurance for ultra-expensive drugs.

Objective

To investigate out-of-pocket spending for ultra-expensive drugs in the Medicare Part D program vs commercial insurance.

Design, setting, and participants

This was a retrospective, population-based cohort study of individuals using ultra-expensive drugs included in a 20% nationally random sample of prescription drug claims from Medicare Part D and individuals aged 45 to 64 years using ultra-expensive drugs included in a large national convenience sample of outpatient pharmaceutical claims from commercial insurance plans. Claims data from 2013 through 2019 were used, and data were analyzed in February 2023.

Main outcomes and

SUBMITTER: DiStefano MJ 

PROVIDER: S-EPMC10220512 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature